Latest topics referred to NICE: October 2012 dh.gov.uk To appraise the clinical and cost effectiveness of rituximab in combination with corticosteroids within its licensed indication for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis. To appraise the clinical and cost ... |
